Altoona Center for Clinical Research, PC

Duncansville, Pennsylvania 16635

1 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Chronic Disease, Dermatomyositis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Pain, Primary Sjogren's Disease, Psoriasis, Rheumatoid Arthritis

Studies at this site

• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease — Recruiting now
• A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis — Completed
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA — Stopped early
• Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis — Completed
• Usability of an AI for M923 in Subjects With Moderate to Severe RA — Completed
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
• Conversion to Embeda With Rescue Trial — Stopped early